Orbimed Advisors Llc's Net Worth
Orbimed Advisors Llc's net worth is estimated to be at least $755,983,495.52 as of 01/31/2023. CoreStreet's estimation of Orbimed Advisors Llc's net worth is based on their sale of stock and current holding of stock.
Orbimed Advisors Llc is Director at Terns Pharmaceuticals Inc. They have executed at least 111 trades of stock as per SEC Form 4 filings. Their most recent trade was for 137,931 units of TERN stock on 12/23/2022. Their biggest sale was on 12/22/2022 when they sold 3,969,496 units of Verona Pharma PLC ADR stock for $86,415,927.92. They typically trade 11 times per year.
Total value of insider buys:
- $169,067,880.93
Total value of insider sells:
- $586,915,614.59
Most recent insider trade:
- Dec. 23, 2022
Orbimed Advisors Llc's Insider Trading History
| Terns Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 23, 2022 | Director | 137,931 | $7.25 | Buy | $999,999.75 |
| Verona Pharma PLC ADR | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 22, 2022 | Director | 3,969,496 | $21.77 | Sell | $86,415,927.92 |
| Scpharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 25, 2022 | Major Shareholder | 762,380 | $5.25 | Buy | $4,002,495.00 |
| Tricida Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 25, 2022 | Director | 3,629,226 | $0.22 | Sell | $798,429.72 |
April 3, 2019 | Director | 225,000 | $36.00 | Buy | $8,100,000.00 |
| Compass Therapeutics Inc. | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 8, 2022 | Director | 402,000 | $3.21 | Buy | $1,290,420.00 |
May 9, 2022 | Director | 90,712 | $1.56 | Buy | $141,510.72 |
May 6, 2022 | Director | 10,200 | $1.63 | Buy | $16,626.00 |
| SpringWorks Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 12, 2022 | Major Shareholder | 153,897 | $31.96 | Sell | $4,918,548.12 |
June 28, 2021 | Major Shareholder | 6,502 | $85.17 | Sell | $553,775.34 |
June 25, 2021 | Major Shareholder | 22,334 | $85.14 | Sell | $1,901,516.76 |
June 23, 2021 | Major Shareholder | 100 | $85.00 | Sell | $8,500.00 |
June 9, 2021 | Major Shareholder | 5,049 | $85.33 | Sell | $430,831.17 |
June 7, 2021 | Major Shareholder | 371 | $84.90 | Sell | $31,497.90 |
| Arcutis Biotherapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 24, 2022 | Major Shareholder | 341,971 | $21.31 | Sell | $7,287,402.01 |
April 8, 2022 | Major Shareholder | 200,000 | $20.71 | Sell | $4,142,000.00 |
April 6, 2022 | Major Shareholder | 333,204 | $20.69 | Sell | $6,893,990.76 |
| Pmv Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 26, 2022 | Major Shareholder | 26,253 | $15.93 | Sell | $418,210.29 |
March 31, 2022 | Major Shareholder | 34,500 | $21.17 | Sell | $730,365.00 |
March 29, 2022 | Major Shareholder | 365,000 | $21.52 | Sell | $7,854,800.00 |
| Edgewise Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 18, 2022 | Director | 138,000 | $7.21 | Buy | $994,980.00 |
| Passage Bio Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 3, 2022 | Major Shareholder | 221,500 | $1.93 | Buy | $427,495.00 |
Jan. 20, 2022 | Major Shareholder | 369,100 | $5.42 | Buy | $2,000,522.00 |
Jan. 18, 2022 | Major Shareholder | 114,700 | $5.46 | Buy | $626,262.00 |
Jan. 13, 2022 | Major Shareholder | 41,800 | $5.52 | Buy | $230,736.00 |
Jan. 11, 2022 | Major Shareholder | 8,200 | $5.53 | Buy | $45,346.00 |
| 89bio Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 25, 2022 | Major Shareholder | 49,091 | $8.40 | Sell | $412,364.40 |
Sept. 21, 2020 | Director | 275,000 | $28.00 | Sell | $7,700,000.00 |
Nov. 11, 2019 | Director | 837,500 | $27.00 | Buy | $22,612,500.00 |
| Corvus Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 20, 2021 | Director | 1,109,644 | $6.09 | Sell | $6,757,731.96 |
Feb. 17, 2021 | Director | 1,285,714 | $3.50 | Buy | $4,499,999.00 |
Aug. 6, 2019 | Director | 142,656 | $3.51 | Buy | $500,722.56 |
July 1, 2019 | Director | 657,344 | $3.72 | Buy | $2,445,319.68 |
June 24, 2016 | Director | 1,000 | $12.98 | Buy | $12,980.00 |
June 21, 2016 | Director | 38,383 | $12.75 | Buy | $489,383.25 |
June 16, 2016 | Director | 20,000 | $12.35 | Buy | $247,000.00 |
May 20, 2016 | Director | 4,716 | $13.09 | Buy | $61,732.44 |
| Alpine Immune Sciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 17, 2021 | Director | 1,010,637 | $9.40 | Buy | $9,499,987.80 |
Dec. 28, 2020 | Director | 600,000 | $14.25 | Sell | $8,550,000.00 |
| Acutus Medical Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 19, 2021 | Director | 1,071,428 | $14.00 | Buy | $14,999,992.00 |
| Imara Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 16, 2021 | Director | 1,666,666 | $6.00 | Buy | $9,999,996.00 |
July 16, 2021 | Director | 1,666,666 | $6.00 | Buy | $9,999,996.00 |
| Neuropace Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 21, 2021 | Major Shareholder | 235,000 | $17.00 | Buy | $3,995,000.00 |
| Oric Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 26, 2021 | Director | 27,816 | $23.88 | Sell | $664,246.08 |
March 24, 2021 | Director | 32,959 | $24.80 | Sell | $817,383.20 |
March 17, 2021 | Director | 18,790 | $28.43 | Sell | $534,199.70 |
March 15, 2021 | Director | 89,210 | $29.14 | Sell | $2,599,579.40 |
March 11, 2021 | Director | 58,551 | $33.04 | Sell | $1,934,525.04 |
April 24, 2020 | Director | 281,250 | $25.68 | Buy | $7,222,500.00 |
| CTi Biopharma Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 7, 2021 | Major Shareholder | 2,000,000 | $3.50 | Sell | $7,000,000.00 |
| Aadi Bioscience Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 8, 2020 | Major Shareholder | 21,400 | $1.96 | Sell | $41,944.00 |
| Inspire Medical Systems Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 17, 2020 | Director | 94,900 | $107.49 | Sell | $10,200,801.00 |
Aug. 7, 2020 | Director | 28,993 | $106.18 | Sell | $3,078,476.74 |
Nov. 27, 2019 | Director | 53,387 | $71.63 | Sell | $3,824,110.81 |
| Alector Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 16, 2020 | Major Shareholder | 62,183 | $23.53 | Sell | $1,463,165.99 |
April 14, 2020 | Major Shareholder | 23,231 | $23.52 | Sell | $546,393.12 |
April 9, 2020 | Major Shareholder | 288,101 | $23.79 | Sell | $6,853,922.79 |
April 7, 2020 | Major Shareholder | 9,170 | $23.10 | Sell | $211,827.00 |
March 31, 2020 | Major Shareholder | 250,000 | $24.50 | Sell | $6,125,000.00 |
March 25, 2020 | Major Shareholder | 56,411 | $24.66 | Sell | $1,391,095.26 |
March 23, 2020 | Major Shareholder | 14,598 | $26.05 | Sell | $380,277.90 |
Jan. 9, 2020 | Major Shareholder | 379,997 | $19.50 | Sell | $7,409,941.50 |
Dec. 17, 2019 | Major Shareholder | 954,100 | $18.52 | Sell | $17,669,932.00 |
Aug. 7, 2019 | Major Shareholder | 650,000 | $17.90 | Sell | $11,635,000.00 |
Feb. 11, 2019 | Director | 411,700 | $19.00 | Buy | $7,822,300.00 |
| Tela Bio Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 8, 2019 | Major Shareholder | 384,615 | $12.09 | Buy | $4,649,995.35 |
| ViewRay Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 20, 2018 | Major Shareholder | 521,607 | $9.95 | Sell | $5,189,989.65 |
Aug. 15, 2018 | Major Shareholder | 185,948 | $9.95 | Sell | $1,850,182.60 |
Aug. 10, 2018 | Major Shareholder | 1,368,796 | $9.97 | Sell | $13,646,896.12 |
Aug. 7, 2018 | Major Shareholder | 169,920 | $11.20 | Sell | $1,903,104.00 |
| Adaptimmune Therapeutics Plc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 6, 2018 | Director | 18,700 | $13.56 | Sell | $253,572.00 |
June 1, 2018 | Director | 171,000 | $13.51 | Sell | $2,310,210.00 |
March 29, 2018 | Director | 1,048,067 | $11.50 | Sell | $12,052,770.50 |
March 27, 2017 | Director | 1,190,476 | $4.20 | Buy | $4,999,999.20 |
May 24, 2016 | Director | 1,712,400 | $10.42 | Buy | $17,843,208.00 |
| Rhythm Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 21, 2018 | Major Shareholder | 131,636 | $30.88 | Sell | $4,064,919.68 |
| Pieris Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 30, 2018 | Insider | 1,000,000 | $6.35 | Sell | $6,350,000.00 |
Feb. 13, 2018 | Major Shareholder | 7,897 | $8.98 | Sell | $70,915.06 |
Jan. 3, 2018 | Major Shareholder | 1,709,620 | $7.35 | Sell | $12,565,707.00 |
Dec. 18, 2017 | Major Shareholder | 147,635 | $5.70 | Sell | $841,519.50 |
| Glaukos Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 6, 2018 | Director | 836,500 | $32.02 | Sell | $26,784,730.00 |
Sept. 5, 2017 | Director | 580,200 | $38.73 | Sell | $22,471,146.00 |
Aug. 17, 2017 | Director | 325,000 | $37.93 | Sell | $12,327,250.00 |
March 14, 2017 | Director | 382,538 | $45.33 | Sell | $17,340,447.54 |
Aug. 3, 2016 | Director | 425,000 | $30.59 | Sell | $13,000,750.00 |
| Kala Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 8, 2018 | Major Shareholder | 25,000 | $12.93 | Buy | $323,250.00 |
Feb. 1, 2018 | Major Shareholder | 362,240 | $15.00 | Buy | $5,433,600.00 |
Jan. 29, 2018 | Major Shareholder | 72,760 | $14.97 | Buy | $1,089,217.20 |
Jan. 26, 2018 | Major Shareholder | 22,760 | $14.93 | Buy | $339,806.80 |
Jan. 24, 2018 | Major Shareholder | 64,637 | $14.91 | Buy | $963,737.67 |
Jan. 22, 2018 | Major Shareholder | 75,000 | $14.98 | Buy | $1,123,500.00 |
Jan. 19, 2018 | Major Shareholder | 74,931 | $14.95 | Buy | $1,120,218.45 |
Jan. 12, 2018 | Major Shareholder | 240,484 | $13.28 | Buy | $3,193,627.52 |
Jan. 10, 2018 | Major Shareholder | 170,338 | $12.83 | Buy | $2,185,436.54 |
July 25, 2017 | Insider | 319,333 | $15.00 | Buy | $4,789,995.00 |
| Aeglea Bio Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 21, 2017 | Major Shareholder | 109,300 | $5.16 | Buy | $563,988.00 |
| Otonomy Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 24, 2015 | Director | 200,800 | $28.56 | Sell | $5,734,848.00 |
| Sientra Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 12, 2015 | Major Shareholder | 287,891 | $5.98 | Sell | $1,721,588.18 |
Oct. 9, 2015 | Major Shareholder | 666,609 | $7.18 | Sell | $4,786,252.62 |
Oct. 6, 2015 | Major Shareholder | 193,000 | $8.71 | Sell | $1,681,030.00 |
Oct. 1, 2015 | Major Shareholder | 101,898 | $10.24 | Sell | $1,043,435.52 |
Sept. 28, 2015 | Major Shareholder | 150,908 | $10.58 | Sell | $1,596,606.64 |
| Sierra Oncology Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 21, 2015 | Director | 175,000 | $17.00 | Buy | $2,975,000.00 |
| Intercept Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 26, 2015 | Director | 157,200 | $286.75 | Sell | $45,077,100.00 |
March 25, 2015 | Director | 207,800 | $274.41 | Sell | $57,022,398.00 |
Aug. 26, 2014 | Director | 111,258 | $298.06 | Sell | $33,161,559.48 |
April 9, 2014 | Director | 81,305 | $320.00 | Sell | $26,017,600.00 |
Oct. 15, 2013 | Director | 376,585 | $62.50 | Sell | $23,536,562.50 |
| Mirati Ther | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 3, 2015 | Major Shareholder | 100,000 | $20.00 | Buy | $2,000,000.00 |
July 1, 2014 | Major Shareholder | 107,332 | $21.66 | Sell | $2,324,811.12 |
Oct. 29, 2013 | Major Shareholder | 125,000 | $17.50 | Buy | $2,187,500.00 |